These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 28572727

  • 1. Organic effects of associating paclitaxel with a lipid-based nanoparticle system on a nonhuman primate, Cebus apella.
    Feio DCA, de Oliveira NCL, Pereira ELR, Morikawa AT, Muniz JAPC, Montenegro RC, Alves APNN, de Lima PDL, Maranhão RC, Burbano RR.
    Int J Nanomedicine; 2017; 12():3827-3837. PubMed ID: 28572727
    [Abstract] [Full Text] [Related]

  • 2. Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion.
    Kretzer IF, Maria DA, Maranhão RC.
    Cell Oncol (Dordr); 2012 Dec; 35(6):451-60. PubMed ID: 23055341
    [Abstract] [Full Text] [Related]

  • 3. Paclitaxel Associated With Lipid Nanoparticles as a New Antiscarring Agent in Experimental Glaucoma Surgery.
    Occhiutto ML, Freitas FR, Lima PP, Maranhão RC, Costa VP.
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):971-8. PubMed ID: 26962693
    [Abstract] [Full Text] [Related]

  • 4. Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice.
    Kretzer IF, Maria DA, Guido MC, Contente TC, Maranhão RC.
    Int J Nanomedicine; 2016 Mar; 11():885-904. PubMed ID: 27022257
    [Abstract] [Full Text] [Related]

  • 5. Regression of Atherosclerotic Plaques of Cholesterol-Fed Rabbits by Combined Chemotherapy With Paclitaxel and Methotrexate Carried in Lipid Core Nanoparticles.
    Gomes FLT, Maranhão RC, Tavares ER, Carvalho PO, Higuchi ML, Mattos FR, Pitta FG, Hatab SA, Kalil-Filho R, Serrano CV.
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):561-569. PubMed ID: 29779420
    [Abstract] [Full Text] [Related]

  • 6. Structural characterization of cholesterol-rich nanoemulsion (LDE).
    Perez AS, Morikawa AT, Maranhão RC, Figueiredo Neto AM.
    Chem Phys Lipids; 2024 Sep; 263():105418. PubMed ID: 38944410
    [Abstract] [Full Text] [Related]

  • 7. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors.
    Ye J, Liu Y, Xia X, Meng L, Dong W, Wang R, Fu Z, Liu H, Han R.
    Oncol Rep; 2016 Jul; 36(1):399-409. PubMed ID: 27175803
    [Abstract] [Full Text] [Related]

  • 8. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor.
    Chen L, Chen B, Deng L, Gao B, Zhang Y, Wu C, Yu N, Zhou Q, Yao J, Chen J.
    Int J Pharm; 2017 Dec 20; 534(1-2):308-315. PubMed ID: 28986321
    [Abstract] [Full Text] [Related]

  • 9. An artificial nanoemulsion carrying paclitaxel decreases the transplant heart vascular disease: a study in a rabbit graft model.
    Lourenço-Filho DD, Maranhão RC, Méndez-Contreras CA, Tavares ER, Freitas FR, Stolf NA.
    J Thorac Cardiovasc Surg; 2011 Jun 20; 141(6):1522-8. PubMed ID: 21458008
    [Abstract] [Full Text] [Related]

  • 10. Use of a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxel.
    Rodrigues DG, Covolan CC, Coradi ST, Barboza R, Maranhão RC.
    J Pharm Pharmacol; 2002 Jun 20; 54(6):765-72. PubMed ID: 12078992
    [Abstract] [Full Text] [Related]

  • 11. Novel formulation of a methotrexate derivative with a lipid nanoemulsion.
    Moura JA, Valduga CJ, Tavares ER, Kretzer IF, Maria DA, Maranhão RC.
    Int J Nanomedicine; 2011 Jun 20; 6():2285-95. PubMed ID: 22072866
    [Abstract] [Full Text] [Related]

  • 12. Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies.
    Rodrigues DG, Maria DA, Fernandes DC, Valduga CJ, Couto RD, Ibañez OC, Maranhão RC.
    Cancer Chemother Pharmacol; 2005 Jun 20; 55(6):565-76. PubMed ID: 15726368
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P, Wang H, Yu M, Liao Z, Wang X, Zhang F, Ji W, Wu B, Han J, Zhang H, Wang H, Chang J, Niu R.
    Eur J Pharm Biopharm; 2012 Jun 20; 81(2):248-56. PubMed ID: 22446630
    [Abstract] [Full Text] [Related]

  • 14. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
    Battogtokh G, Kang JH, Ko YT.
    Eur J Pharm Biopharm; 2015 Oct 20; 96():96-105. PubMed ID: 26212785
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of paclitaxel carried in lipid nanoparticles to treat aortic allograft transplantation in rats.
    Pepineli R, Santana AC, Silva FMO, Tavoni TM, Stolf NAG, Noronha IL, Maranhão RC.
    J Pharm Pharmacol; 2021 Jul 07; 73(8):1092-1100. PubMed ID: 33950246
    [Abstract] [Full Text] [Related]

  • 17. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G, Wang Z, Li C, Duan G, Wang K, Li Q, Tao T.
    Biomed Pharmacother; 2018 Oct 07; 106():275-284. PubMed ID: 29966971
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors.
    Teixeira RS, Valduga CJ, Benvenutti LA, Schreier S, Maranhão RC.
    J Pharm Pharmacol; 2008 Oct 07; 60(10):1287-95. PubMed ID: 18812021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.